Journal of Tissue Engineering and Regenerative Medicine,
Journal Year:
2024,
Volume and Issue:
2024, P. 1 - 11
Published: Jan. 6, 2024
In
rheumatoid
arthritis,
dysregulated
cytokine
signaling
has
been
implicated
as
a
primary
factor
in
chronic
inflammation.
Many
antirheumatic
and
biological
therapies
are
used
to
suppress
joint
inflammation,
but
despite
these
advances,
effectiveness
is
not
universal,
delivery
often
at
high
doses,
which
can
predispose
patients
significant
off-target
effects.
During
the
inappropriate
regulation
of
factors
by
macrophages
accelerates
progression
disease
driving
an
imbalance
inflammatory
cytokines,
making
ideal
cellular
target.
To
develop
macrophage-based
therapy
treat
we
engineered
novel
induced
pluripotent
stem
cell
(iPSC)-derived
macrophage
capable
delivering
soluble
TNF
receptor
1
(TNFR1),
anti-inflammatory
biologic
inhibitor
tumor
necrosis
alpha
(TNF-α),
auto-regulated
manner
response
TNF-α.
Murine
iPSCs
were
differentiated
into
(iMACs)
over
17-day
optimized
protocol
with
continued
successful
differentiation
confirmed
key
timepoints.
Varying
immunomodulatory
stimuli
demonstrated
traditional
function
phenotypes.
TNF-α,
therapeutic
iMACs
produced
levels
sTNFR1
autoregulated
manner,
inhibited
signaling.
This
self-regulating
iMAC
system
potential
for
drug
approach
variety
diseases.
Biomedicines,
Journal Year:
2023,
Volume and Issue:
11(10), P. 2655 - 2655
Published: Sept. 28, 2023
Cervical
cancer
(CC)
is
a
serious
global
health
issue,
and
it
well-known
that
HPV
infection
the
main
etiological
factor
triggers
carcinogenesis.
In
cancer,
chemokine
ligands
receptors
are
involved
in
tumor
cell
growth,
metastasis,
leukocyte
infiltration,
angiogenesis;
however,
information
on
role
played
by
E6/E7
of
HPV16/18
modulation
chemokines
very
limited.
Therefore,
this
study
aimed
to
determine
whether
differentially
expressed
CC-derived
lines;
if
oncoproteins
from
HPV16
18
capable
mediating
expression,
what
expression
profile
tissues
derived
CC
their
impact
overall
survival
patients
with
pathology?
For
purpose,
RNA
sequencing
real-time
PCR
were
performed
SiHa,
HeLa,
C33A
tumorigenic
lines,
non-tumorigenic
HaCaT
cells,
HPV-transduced
models.
Furthermore,
analysis
executed
304
22
normal
tissue
samples
The
Cancer
Genome
Atlas
(TCGA)
repository.
results
demonstrate
CXCL1,
CXCL2,
CXCL3,
CXCL8
regulated
18,
overexpressed
biopsies,
higher
related
worse
prognostic
survival.
Frontiers in Pain Research,
Journal Year:
2024,
Volume and Issue:
5
Published: Jan. 18, 2024
Objectives
This
explorative
study
analyses
interrelationships
between
peripheral
compounds
in
saliva,
plasma,
and
muscles
together
with
body
composition
variables
healthy
subjects
fibromyalgia
patients
(FM).
There
is
a
need
to
better
understand
the
extent
cytokines
chemokines
are
associated
which
differentiate
FM
from
controls.
Methods
Here,
32
female
30
age-matched
controls
underwent
clinical
examination
that
included
blood
sample,
saliva
samples,
pain
threshold
tests.
In
addition,
completed
health
questionnaire.
From
these
panel
of
68
mainly
were
determined.
Microdialysis
trapezius
erector
spinae
muscles,
phosphorus-31
magnetic
resonance
spectroscopy
muscle,
whole-body
imaging
for
determination
(BC)—i.e.,
muscle
volume,
fat
content
infiltration—were
also
performed.
Results
After
standardizing
BC
measurements
remove
confounding
effect
Body
Mass
Index,
infiltration
generally
increased,
fat-free
volume
decreased
FM.
Mainly
proteins
differentiated
When
including
all
investigated
variables,
most
important,
followed
by
plasma.
Various
plasma
correlated
positively
intensity
negatively
thresholds
taken
together.
A
mix
increased
an
index
covering
different
tissues.
analysis,
several
identified
as
important
regressors,
although
many
remained
significant.
Discussion
Peripheral
factors
group
differentiation
(but
not
plasma),
significantly
membership
The
importance
when
included.
Plasma
sensitivity.
Cytokines
index.
Conclusion
Our
findings
associations
tissues
confirm
inflammation
immune
secreted
adipose
tissue.
clearly
characterized
complex
interactions
central
nervous
systems,
nociceptive,
immune,
neuroendocrine
processes.
American Journal of Cancer Research,
Journal Year:
2024,
Volume and Issue:
14(1), P. 274 - 299
Published: Jan. 1, 2024
The
microbiota
residing
in
the
gut
environment
is
essential
for
host
homeostasis.Increasing
evidence
suggests
that
microbial
perturbation
(dysbiosis)
regulates
cancer
initiation
and
progression
at
local
distant
sites.Here,
we
have
identified
dysbiosis
with
depletion
of
commensal
bacteria
as
a
host-intrinsic
factor
associated
metastatic
dissemination
to
bone.Using
mouse
model
triple-negative
mammary
cancer,
demonstrate
pre-established
disruption
homeostasis
using
an
antibiotic
cocktail
increases
tumor
growth,
enhanced
circulating
cells,
subsequent
bone.We
found
presence
pathogenic
loss
antibiotic-induced
sustained
inflammation.Increased
secretion
G-CSF
MMP-9
intestinal
tissues,
followed
by
increased
neutrophil
infiltration
severe
systemic
inflammation
tumor-bearing
mice,
indicates
direct
consequence
dysbiotic
microbiome.Increased
bone
niche
facilitates
extravasation
transendothelial
migration
cells.It
provides
novel,
pre-established,
favorable
form
immunosuppressive
pre-metastatic
niche.The
cells
disrupts
balance
between
osteoblasts
osteoclasts,
promotes
osteoclast
differentiation,
remodels
structure.Excessive
resorption
osteoclasts
causes
degradation
ultimately
extreme
pain
model.In
clinical
settings,
metastasis
intractable
severely
compromises
quality
life
these
patients.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
15
Published: Jan. 20, 2025
Background
Intestinal
ischemia-reperfusion
injury
(IIRI)
is
a
severe
clinical
condition
associated
with
high
morbidity
and
mortality.
Despite
advances
in
understanding
the
pathophysiology
of
IIRI,
effective
diagnostic
therapeutic
strategies
remain
limited.
Methods
Using
transcriptome
sequencing
mouse
model
we
identified
potential
biomarkers
that
were
significantly
upregulated
IIRI
group
compared
to
sham
group.
Based
on
these
findings,
developed
evaluated
strategy
using
milk-derived
exosomes
loaded
siRNA
targeting
CCL7
(M-Exo/siCCL7).
Results
Focusing
Ccl7
as
hub
gene,
explored
efficacy
(M-Exo/siCCL7)
model.
M-Exo/siCCL7
treatment
effectively
attenuated
intestinal
inflammation
injury,
evidenced
by
reduced
histological
damage,
decreased
serum
markers
barrier
dysfunction,
systemic
inflammation.
Conclusion
Our
findings
provide
new
insights
into
molecular
mechanisms
underlying
identify
biomarkers,
highlight
promise
exosome-based
delivery
novel
approach
for
IIRI.
Abstract
Increasing
knowledge
of
the
immunosuppressive
tumor
microenvironment
in
cancer-related
processes
has
led
to
developing
novel
immune-based
therapies
that
have
changed
cancer
treatment
paradigm.
In
microenvironment,
plethora
soluble
factors
secreted
by
cells
interacts
with
immune
and
non-immune
components
deliver
signals
necessary
for
progression.
Accordingly,
targeting
tumor-derived
inducing
this
become
an
appealing
therapeutic
potential
advancing
treatment.
CCL20,
a
chemokine
best
known
induce
leucocyte
migration
response
pathological
inflammatory
conditions,
been
implicated
proliferation,
angiogenesis,
metastasis,
immunosuppression,
resistance.
Notably,
CCL20
its
receptor
CCR6
are
important
interactions.
This
review
discusses
interaction
between
CCL20–CCR6
axis
how
these
interactions
promote
Also,
outline
studies
utilizing
combination
other
standard
treatments
shed.
Discover Oncology,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: March 4, 2025
C–C
Motif
Chemokine
Ligand
5
(CCL5)
is
known
for
its
role
in
immune
regulation
and
has
been
implicated
cancer
progression.
However,
expression
prognostic
significance
pan-cancer
require
comprehensive
evaluation.
This
study
was
initiated
to
decipher
the
of
CCL5
genes.
In
silico
analyses
involving
various
online
databases
molecular
experiments
knockdown
KIRC
cell
lines
evaluated
proliferation,
colony
formation,
migration.
significantly
up-regulated
several
cancers.
High
correlated
with
poorer
overall
survival
kidney
renal
carcinoma
(KIRC)
esophageal
(ESCA)
patients.
Promoter
hypomethylation
elevated
prognosis.
mutations
were
rare;
indicating
driven
by
overexpression
rather
than
genetic
alterations.
Positive
correlations
inhibitory
MHC
genes
suggested
CCL5's
fostering
an
immunosuppressive
tumor
microenvironment.
increased
infiltration,
particularly
CD8
T
cells
macrophages.
did
not
influence
drug
sensitivity.
resulted
reduced
migration,
underscoring
critical
dynamics.
Our
highlights
progression
prognosis,
ESCA.
modulating
microenvironment
potential
as
a
therapeutic
target
warrant
further
investigation.
Clinical and Experimental Medicine,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: March 6, 2025
Graft-versus-host
disease
remains
one
of
the
most
formidable
barriers
to
complete
success
hematopoietic
stem
cell
transplantation
that
has
emerged
as
curative
approach
for
many
malignancies
because
it
affects
quality
life
and
overall
survival.
Macrophages
are
among
important
members
immune
system,
which
perform
dual
roles
in
GVHD
both
therapeutic
tools
targets.
This
review
epitomizes
multifunctional
role
macrophages
pathophysiology
acute
chronic
GVHD.
play
an
early
phase
their
recruitment
infiltration
into
target
organs.
Furthermore,
they
polarize
two
functionally
different
phenotypes,
including
M1
M2.
In
case
GVHD,
express
phenotype
characterized
by
production
pro-inflammatory
cytokines
contribute
tissue
damage.
contrast,
tend
toward
M2
associated
with
repair
tissues
fibrosis.
A
critical
balance
these
phenotypes
is
central
course
severity
Further
interactions
other
lymphocytes
such
T
cells,
B
fibroblast
further
determine
Macrophage
interaction
alloreactive
cells
promotes
inflammation.
therefore
inducing
injuries
during
Interaction
macrophages,
cell,
fibroblast,
CD4+
fibrosis
and,
hence,
subsequent
dysfunction
These
some
insights,
while
several
challenges
remain.
First,
impact
dominant
on
polarization
incompletely
sometimes
controversial.
Second,
development
targeted
therapies
able
modulate
macrophage
function
without
systemic
side
effects
area
ongoing
investigation.
Future
directions
involve
exploration
macrophage-targeted
therapies,
small
molecules,
antibodies,
nanotechnology,
behavior
improve
patient
outcomes.
underlines
fact
a
profound
understanding
essential
developing
new
more
effective
strategies.
Targeting
might
represent
avenue
decreasing
incidence
improving
safety
HSCT.
Journal of Experimental & Clinical Cancer Research,
Journal Year:
2022,
Volume and Issue:
41(1)
Published: Nov. 17, 2022
Abstract
Background
Poor
infiltration
of
functioning
T
cells
renders
tumors
unresponsive
to
checkpoint-blocking
immunotherapies.
Here,
we
identified
a
combinatorial
in
situ
immunomodulation
strategy
based
on
the
administration
selected
immunogenic
drugs
and
immunotherapy
sensitize
poorly
T-cell-infiltrated
neuroblastoma
(NB)
host
antitumor
immune
response.
Methods
975A2
9464D
NB
cell
lines
derived
from
spontaneous
TH-MYCN
transgenic
mice
were
employed
study
drug
combinations
able
enhancing
response
using
vivo
ex
approaches.
Migration
towards
drug-treated
murine-derived
organotypic
tumor
spheroids
(MDOTS)
assessed
by
microfluidic
devices.
Activation
status
co-cultured
with
MDOTS
was
evaluated
flow
cytometry
analysis.
The
effect
treatment
content
subcutaneous
or
orthotopic
comprehensively
analyzed
flow-cytometry,
immunohistochemistry
multiplex
immunofluorescence.
chemokine
array
assay
used
detect
soluble
factors
released
into
microenvironment.
Patient-derived
(PDOTS)
generated
human
specimens.
activation
autologous
PDOTS
performed.
Results
We
found
that
low-doses
mitoxantrone
(MTX)
recalled
promoted
CD8
+
NK
when
combined
TGFβ
PD-1
blockade.
This
curbed
growth
resulting
enrichment
variety
both
lymphoid
myeloid
cells,
especially
intratumoral
dendritic
(DC)
IFNγ-
granzyme
B-expressing
cells.
A
concomitant
production
inflammatory
chemokines
involved
remodelling
landscape
also
detected.
Interestingly,
this
induced
recruitment
against
Conclusions
Combined
low-dose
MTX
anti-TGFβ
blockade
improves
immunity
overcoming
immunosuppressive
microenvironment
aggressive
NB.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: May 29, 2024
Hepatocellular
carcinoma
(HCC)
is
one
of
the
most
prevalent
malignancies
worldwide
and
has
a
poor
prognosis.
Although
immune
checkpoint
inhibitors
have
entered
new
era
HCC
treatment,
their
response
rates
are
modest,
which
can
be
attributed
to
immunosuppressive
tumor
microenvironment
within
tumors.
Accumulating
evidence
shown
that
growth
fueled
by
cancer
stem
cells
(CSCs),
contribute
therapeutic
resistance
above
treatments.
Given
CSCs
regulate
cellular
physical
factors
niche
secreting
various
soluble
in
paracrine
manner,
there
been
increasing
efforts
toward
understanding
roles
CSC-derived
secretory
creating
an
microenvironment.
In
this
review,
we
provide
update
on
how
these
factors,
including
cytokines,
chemokines,
exosomes,
TME,
leads
resistance.
addition,
present
current
strategies
targeting
describe
future
perspectives.
summary,
better
CSC
biology
TME
provides
rational
basis
for
combination
therapy
with
ICIs
effective
treatment.